Form 990 for tax year 2022
Filed by TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION.
Totals
- Total revenue
- $610,734
- Total expenses
- $868,351
- Contributions and grants received
- $610,734
- Grants paid
- $527,168
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
- Total assets, end of year
- $447,207
- Total liabilities, end of year
- $5,203
- Net assets or fund balances, end of year
- $442,004
- Program services expenses (Part IX)
- $765,079
- Management and general expenses
- $40,554
- Fundraising expenses
- $62,718
- Program service expenses (Part III)
- $765,079
Program services were 88.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$15,000
-
1f · All other contributions, gifts and grants
$595,734
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $336,274 · program services $336,274
-
3 · Grants to foreign organizations and individuals
total $190,894 · program services $190,894
-
7 · Other salaries and wages
total $202,645 · program services $152,361 · management and general $14,034 · fundraising $36,250
-
10 · Payroll taxes
total $17,234 · program services $13,041 · management and general $1,286 · fundraising $2,907
-
11c · Fees: accounting
total $4,242 · management and general $4,242
-
11g · Fees: other
total $14,852 · program services $10,156 · management and general $3,096 · fundraising $1,600
-
12 · Advertising and promotion
total $1,141 · program services $826 · management and general $48 · fundraising $267
-
13 · Office expenses
total $5,822 · program services $3,091 · management and general $1,632 · fundraising $1,099
-
14 · Information technology
total $12,711 · program services $10,019 · management and general $2,182 · fundraising $510
-
16 · Occupancy
total $13,027 · program services $800 · management and general $12,227
-
17 · Travel
total $5,880 · program services $5,036 · fundraising $844
-
19 · Conferences, conventions and meetings
total $42,188 · program services $42,188
-
23 · Insurance
total $1,537 · management and general $1,537
-
24a · Other expenses: Other
total $19,904 · program services $393 · management and general $270 · fundraising $19,241
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $691,851 · end of year $424,997
-
4 · Accounts receivable
beginning of year $24,180 · end of year $20,347
-
15 · Other assets
beginning of year $1,863 · end of year $1,863
-
17 · Accounts payable and accrued expenses
beginning of year $18,273 · end of year $5,203
-
27 · Net assets without donor restrictions
beginning of year $699,621 · end of year $442,004
Mission and programs · 2022
Mission
Tess Research Foundations goal is to find better treatment options for SLC13A5 deficiency, (Continued on Sch O)
-
Funding Scientific Research - We continued our in-person, digital and remote natural history studies for SLC13A5with Citizen Corporation, Brown University, UT Southwestern, and Stanford University. These studies are key for our clinical trial readiness. We also funded basic and translational research in the US and Europe.
Expenses $633,004 · Grants $521,118
-
Education, Family Support and Awareness - We helped more families find an early and accurate diagnosis. Wepublished in peer reviewed journals, held monthly family support groups, and funded key research to better understand the disease, and we have our first gene therapy drug in development.
Expenses $83,910 · Grants $1,050
-
Conference - We continue to create a patient-centered network of doctors, researchers, clinicians and families. We hosted an International Research Roundtable and a Clinical Research Conference. We attended professionalconferences in the epilepsy and rare disease space. We remain the only organization in the world solely dedicated to this disorder.
Expenses $48,165 · Grants $5,000
As filed on the 2022 return.
Listed in Part VII
-
Adam Alberti
Director
- Total calculated
- $0
- Hours/week
- 2
-
Lee Scheuer
Director
- Total calculated
- $0
- Hours/week
- 3
-
Robert Wassman
Director
- Total calculated
- $0
- Hours/week
- 3
-
Courtney Alberti
Director
- Total calculated
- $0
- Hours/week
- 2
-
Paula Gani
Secretary
- Total calculated
- $0
- Hours/week
- 5
-
Kimberly Nye
President
- Total calculated
- $0
- Hours/week
- 40
-
Kevin McDonnell
Treasurer
- Total calculated
- $0
- Hours/week
- 3
-
Amber Black
Vice Chair
- Total calculated
- $0
- Hours/week
- 5
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
$136,224
SLC13A5 Natural History Study
-
$100,000
New research tool for the SLC13A5 commun
-
Modulation of NaCT Function for the Trea
-
Texas Tech University Health Scienc
$25,000
Development of correctors to rescue muta
-
Laxai Avanti Life Sciences Inc
$14,800
Compound synthesis
-
$10,000
Matching Grant for SLC13A5 Research
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 27 September 2023
- IRS schema version
- 2022v5.0
- Source object
- 202332709349300128
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.